EUVIMEDEUVIMED entdecken
Crossref

Targeting formyl peptide receptor 1 reduces brain inflammation and neurodegeneration

Yulin Li iD, Zhiguo Li iD, Pei Zheng iD, Shuzhen Guan iD, Yan Li iD, Nan Yao iD, Zhihui Qi, Xueyu Zhang iD, Lei Su, Jing Jing iD, Siting Wu, Xue Zhao und 7 weitere

Science · 13.11.2025 · 390 (6774)

DOI: 10.1126/science.adq1177 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 13.11.2025. Verfasst von Yulin Li und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Tianjin Medical University General Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Receptors, Formyl Peptide, Multiple Sclerosis. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple sclerosis (MS) progresses through brain region–specific inflammation and degeneration, with poorly defined mechanisms. In individuals with MS, we identified increased expression of formyl peptide receptor 1 (FPR1) in central nervous system (CNS)–resident microglia and CNS-infiltrating macrophages. Blood amounts of N -formylated peptides, which are endogenous agonists of FPR1, correlated with disease progression in patients with MS. In MS mouse models, signaling through FPR1 promoted microglial mitochondrial dysfunction, causing axonal loss and apoptosis. FPR1-expressing microglia sustained the clonal expansion of myelin-reactive CD4 + T cells in the CNS. A CNS-penetrating small molecule FPR1 antagonist, T0080, mitigated autoimmune responses and axonal degeneration. Our study identifies FPR1 signaling as a potential mechanism for MS progression and suggests antagonizing FPR1 as a therapeutic approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Formyl PeptideMultiple SclerosisAnimalsMiceMicrogliaHumansEncephalomyelitis, Autoimmune, ExperimentalApoptosisSignal TransductionAxonsMacrophagesMitochondriaCD4-Positive T-LymphocytesFemaleMaleDisease ProgressionMice, Inbred C57BLBrainDisease Models, Animal

Substanzen

Receptors, Formyl PeptideFPR1 protein, humanFpr1 protein, mouse

Autor:innen und Institutionen

  • Department of Neurology, Tianjin Medical University General Hospital, Tianjin, China.
  • Department of Neurology, Tiantan Neuroimaging Center of Excellence, China National Clinical Research Canter for Neurological Disease, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin and Max Delbrueck Center for Molecular Medine, Berlin, Germany.
  • Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Faculty of Biology, Medicine and Health, the University of Manchester, Manchester, UK.

ORCID-Profile: Yulin Li, Zhiguo Li, Pei Zheng, Shuzhen Guan, Yan Li, Nan Yao, Xueyu Zhang, Jing Jing, Chotima Böttcher, Hans-Gustaf Ljunggren, Friedemann Paul, Luc Van Kaer, Alexei Verkhratsky, Fu-Dong Shi

Zitieren

APA

Li, Y., Li, Z., Zheng, P., Guan, S., Li, Y., Yao, N., Qi, Z., Zhang, X., Su, L., Jing, J., Wu, S., Zhao, X., Wang, M., Böttcher, C., Ljunggren, H. G., Paul, F., Van Kaer, L., Verkhratsky, A., & Shi, F. D. (2025). Targeting formyl peptide receptor 1 reduces brain inflammation and neurodegeneration. Science, 390(6774). https://doi.org/10.1126/science.adq1177

Vancouver

Li Y, Li Z, Zheng P, Guan S, Li Y, Yao N, et al. Targeting formyl peptide receptor 1 reduces brain inflammation and neurodegeneration. Science. 2025;390(6774). doi:10.1126/science.adq1177

BibTeX
@article{Li2025,
  author = {Li, Yulin and Li, Zhiguo and Zheng, Pei and Guan, Shuzhen and Li, Yan and Yao, Nan and Qi, Zhihui and Zhang, Xueyu and Su, Lei and Jing, Jing and Wu, Siting and Zhao, Xue and Wang, Meng and Böttcher, Chotima and Ljunggren, Hans-Gustaf and Paul, Friedemann and Van Kaer, Luc and Verkhratsky, Alexei and Shi, Fu-Dong},
  title = {Targeting formyl peptide receptor 1 reduces brain inflammation and neurodegeneration},
  journal = {Science},
  year = {2025},
  volume = {390},
  number = {6774},
  doi = {10.1126/science.adq1177}
}
Kostenlos starten →